Treating pediatric patients with obstructive sleep disorders: an update

Anna H Messner1

  • 1Division of Otolaryngology/Head and Neck Surgery, Room R135, Edwards Building, Stanford University, Stanford, CA 94305-5328, USA. amessner@stanfordmed.org

Insights

Obstructive sleep apnea syndrome (OSAS) in children is common. Tonsillectomy and adenoidectomy (T&A) is the preferred treatment, with ongoing research into optimal surgical techniques and proven quality-of-life benefits.

Area of Science:

  • Otolaryngology
  • Pediatric Sleep Medicine
  • Surgical Techniques

Background:

  • Obstructive sleep apnea syndrome (OSAS) is prevalent in children, posing a significant challenge for otolaryngologists.
  • Current diagnostic and treatment pathways for pediatric OSAS are subjects of ongoing discussion.
  • Tonsillectomy and adenoidectomy (T&A) is widely recognized as the primary surgical intervention for pediatric OSAS.

Purpose of the Study:

  • To review the current landscape of pediatric obstructive sleep apnea syndrome.
  • To discuss the established role and evolving techniques of T&A in managing pediatric OSAS.
  • To highlight the positive impact of T&A on children's quality of life.

Main Methods:

  • Literature review focusing on pediatric OSAS prevalence, diagnosis, and treatment outcomes.
  • Analysis of current T&A surgical methodologies, including "cold" and "hot" techniques.
  • Evaluation of quality-of-life metrics in pediatric patients post-T&A.

Main Results:

  • T&A remains the optimal treatment for pediatric OSAS, despite some controversy in evaluation methods.
  • Both "cold" and "hot" tonsillectomy techniques are considered standard surgical options.
  • Quality-of-life assessments consistently demonstrate significant improvements following T&A.

Conclusions:

  • Pediatric OSAS is a critical area within otolaryngology requiring effective management strategies.
  • T&A is a highly effective treatment for pediatric OSAS, with established benefits.
  • Continued research into optimizing T&A techniques may further enhance patient outcomes.

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...